108 results
Page 5 of 6
8-K
EX-99.1
9ohns7x8iw3l
9 Aug 18
Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B5
zp48mavb
7 Jun 18
Prospectus supplement for primary offering
5:13pm
8-K
EX-1.1
rr1yg i52s0m5h
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
424B5
oj4wjmkbv lacldr
6 Jun 18
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
xmh7qc9w y2mqavkm7
9 May 18
Viking Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B4
awkssd4i65o
8 Apr 16
Prospectus supplement with pricing info
12:00am
10-K
4dsh49h9g dbi6zy
8 Mar 16
Annual report
12:00am